Wave Bioreactors Added To Macrogenics cGMP Manufacturing Facility
Source: Wave Biotech (Now Part Of GE Healthcare)
Wave Biotech, LLC has announced that MacroGenics, a biotechnology company headquartered in Rockville, Maryland, has installed 200-liter Wave Bioreactors® in its new facility. The Wave Bioreactors will enable MacroGenics - which is focused on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases - to produce monoclonal antibodies under current Good Manufacturing Practice (cGMP) standards.
access the Download!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
This website uses cookies to ensure you get the best experience on our website. Learn more